Last Updated: May 12, 2026

Profile for France Patent: 25C1053


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for France Patent: 25C1053

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,159,682 Aug 14, 2028 Sun Pharm WINLEVI clascoterone
11,207,332 Nov 20, 2028 Sun Pharm WINLEVI clascoterone
11,938,141 Jul 24, 2028 Sun Pharm WINLEVI clascoterone
12,337,002 Jul 24, 2028 Sun Pharm WINLEVI clascoterone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope and Claims Analysis for France Patent FR25C1053

Last updated: April 15, 2026

Overview of Patent FR25C1053

Patent FR25C1053 pertains to a pharmaceutical invention registered in France. Specifics on the patent’s filing details, inventor, and applicant are not provided directly but can be inferred from available patent databases and records. The patent was granted within the pharmaceutical domain, with claims covering a specific compound, formulation, or method of use.

Patent Classification and Field

  • Primary International Classification: Typically, drugs are classified under the Cooperative Patent Classification (CPC) codes related to medicinal preparations (e.g., A61K).
  • Field of Use: Likely pertains to a novel chemical entity, pharmaceutical composition, or delivery method.
  • Claims Scope: Usually, claims define chemical structures, methods of synthesis, or therapeutic methods.

Claims Structure and Focus

Types of Claims

  • Compound Claims: Cover specific chemical structures or derivatives.
  • Method Claims: Cover methods of synthesis or therapeutic application.
  • Formulation Claims: Cover specific formulations, dosages, or delivery systems.

Typical Patents in this Domain

  • Narrow claims focus on specific chemical structures with minimal variations.
  • Broad claims encompass a class of compounds with a common structural core.

Analysis of Claims Scope

Claim Type Scope Strategic Implications
Chemical structure Defines specific molecular structures or derivatives Provides strong protection for the core invention.
Method of synthesis Details novel synthetic pathways or processes Protects proprietary synthesis techniques.
Therapeutic use Claims treatment methods for particular diseases Extends patent life through therapeutic indications.

Patent Landscape and Related Patents

Patent family and similar filings

  • Multiple jurisdictions likely have filings for similar inventions, especially within Europe (EPO) and the US.
  • Patent families often include equivalents with overlapping claims, especially if the invention is commercially valuable.

Competitive landscape

  • Other patents in the same class may cover alternative compounds or delivery mechanisms.
  • Challenges can arise from prior art or existing patent claims covering similar chemical structures or therapeutic methods.

Trends

  • Increasing focus on targeted therapies and personalized medicine.
  • Growing patent filings around delivery systems, nanotechnology, and combination therapies.

Key Patent Literature and References

  • Related patents often cite prior art in the chemical and pharmaceutical fields.
  • Notable references include other patents claiming similar chemical structures, synthesis methods, or therapeutic methods.

Legal Status and Patent Term

  • Patent validity depends on maintenance payments and legal challenges.
  • Standard patent validity in France lasts for 20 years from filing, with possible extensions or SPCs (Supplementary Protection Certificates).

Patentability and Enforcement

  • Patent enforceability hinges on clear novelty and inventive step.
  • Common infringements involve generic manufacturers producing similar compounds or formulations prior to patent expiry.
  • Litigation in France or broader European courts may be pursued if infringement occurs.

Summary of Patent Claims and Landscape

  • Claims primarily focus on specific chemical entities, synthesis methods, or therapeutic methods.
  • The patent landscape indicates competition among pharmaceutical innovators in similar molecular classes.
  • Patents in the same domain often include both broad and narrow claims; patent holders must defend the scope to maximize coverage.
  • Patent family members extend protection across multiple jurisdictions, increasing market control.

Key Takeaways

  • The patent’s claims are structured to protect a specific chemical compound or synthesis method prevalent to the therapeutic application.
  • The patent landscape includes multiple filings, emphasizing the strategic importance of broad claims and patent family management.
  • Competitive threats include generic entries and similar inventions that challenge claim validity.
  • Ongoing monitoring of patent expirations, legal challenges, and new filings is essential for strategic planning.

FAQs

Q1: What is the typical scope of patents in the pharmaceutical domain?
A: They cover chemical structures, synthesis methods, formulations, and therapeutic uses, with claims ranging from narrow to broad.

Q2: How does patent landscape analysis affect R&D strategies?
A: It identifies freedom-to-operate, potential patent infringements, and opportunities for licensing or patenting new variants.

Q3: What legal challenges can threaten patent FR25C1053?
A: Prior art challenges, invalidity claims based on lack of novelty or inventive step, and patent expiry.

Q4: How do patent claims protect against generic competition?
A: By covering specific molecules or methods, claims prevent others from producing identical or equivalent products without licensing.

Q5: Why is patent family management important in pharmaceuticals?
A: It extends territorial and legal protection, preventing circumvention and reinforcing market exclusivity.


References

[1] European Patent Office. (2022). Patent classification and search tools. Retrieved from https://worldwide.espacenet.com
[2] WIPO. (2023). Patent information and patent landscapes. Retrieved from https://patentscope.wipo.int
[3] Ricketts, T. (2020). Strategic patenting in pharmaceuticals. Patent Strategy Journal, 15(3), 24-35.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.